Autoantibodies involved in primary and secondary adrenal insufficiency following treatment with immune checkpoint inhibitors

por Helderman, N.C., Lucas, M.W., Blank, C.U.
Publicado 2023

Surgical removal of the index node marked using magnetic seed localization to assess response to neoadjuvant immunotherapy in patients with stage III melanoma

por Schermers, B., Franke, V., Rozeman, E. A., van de Wiel, B. A., Bruining, A., Wouters, M. W., van Houdt, W. J., ten Haken, B., Muller, S. H., Bierman, C., Ruers, T. J. M., Blank, C. U., van Akkooi, A. C. J.
Publicado 2019

Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections

por Schmitt, C., Hoefsmit, E. P., Fangmeier, T., Kramer, N., Kabakci, C., Vera González, J., Versluis, J. M., Compter, A., Harrer, T., Mijočević, H., Schubert, S., Hundsberger, T., Menzies, A. M., Scolyer, R. A., Long, G. V., French, L. E., Blank, C. U., Heinzerling, L. M.
Publicado 2023

Combining Hepatic Percutaneous Perfusion with Ipilimumab plus Nivolumab in advanced uveal melanoma (CHOPIN): study protocol for a phase Ib/randomized phase II trial

por Tong, T. M. L., van der Kooij, M. K., Speetjens, F. M., van Erkel, A. R., van der Meer, R. W., Lutjeboer, J., van Persijn van Meerten, E. L., Martini, C. H., Zoethout, R. W. M., Tijl, F. G. J., Blank, C. U., Burgmans, M. C., Kapiteijn, E.
Publicado 2022

Conversion of unresponsiveness to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma: study protocol for a randomized phase Ib/II...

por Borgers, J. S. W., Burgers, F. H., Terveer, E. M., van Leerdam, M. E., Korse, C. M., Kessels, R., Flohil, C. C., Blank, C. U., Schumacher, T. N., van Dijk, M., Henderickx, J. G. E., Keller, J. J., Verspaget, H. W., Kuijper, E. J., Haanen, J. B. A. G.
Publicado 2022

Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers

por Trebeschi, S, Drago, S G, Birkbak, N J, Kurilova, I, Cǎlin, A M, Delli Pizzi, A, Lalezari, F, Lambregts, D M J, Rohaan, M W, Parmar, C, Rozeman, E A, Hartemink, K J, Swanton, C, Haanen, J B A G, Blank, C U, Smit, E F, Beets-Tan, R G H, Aerts, H J W L
Publicado 2019

LBA8 Vaccination against SARS-CoV-2 in patients receiving chemotherapy, immunotherapy, or chemo-immunotherapy for solid tumors

por Oosting, S., Van der Veldt, A.A.M., GeurtsvanKessel, C.H., Fehrmann, R.S.N., van Binnendijk, R.S., Dingemans, A-M.C., Smit, E.F.F., Hiltermann, T.J.N., den Hartog, G., Jalving, M., Westphal, T., Battacharya, A., van der Heiden, M., Blank, C.U., Koopmans, M.P., van Els, C.A., Rots, N.Y., van Baarle, D., Haanen, J.B.A.G., de Vries, E.G.
Publicado 2021

MART-1 TCR gene-modified peripheral blood T cells for the treatment of metastatic melanoma: a phase I/IIa clinical trial

por Rohaan, M.W., Gomez-Eerland, R., van den Berg, J.H., Geukes Foppen, M.H., van Zon, M., Raud, B., Jedema, I., Scheij, S., de Boer, R., Bakker, N.A.M., van den Broek, D., Pronk, L.M., Grijpink-Ongering, L.G., Sari, A., Kessels, R., van den Haak, M., Mallo, H.A., Karger, M., van de Wiel, B.A., Zuur, C.L., Duinkerken, C.W., Lalezari, F., van Thienen, J.V., Wilgenhof, S., Blank, C.U., Beijnen, J.H., Nuijen, B., Schumacher, T.N., Haanen, J.B.A.G.
Publicado 2022